The therapeutic effect of myocardin on treatment of diabetic and obesity cardiomyocytes, as well as the mechanism underlying systemic insulin resistance and reduction of myocardin in heart warrants future study. Here, MYOCD is linked to obesity due to melanocortin 4 receptor deficiency.